Marcelo Iastrebner
B, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Outcomes of Allogeneic Hematopoietic Cell Transplantation for Hypoplastic Myelodysplastic Syndrome: A Latin American Multicenter Analysis.
Journal: Transplantation and cellular therapy
Published: January 05, 2026
Outcomes After Allogeneic Hematopoietic Cell Transplantation in Adults With Myelodysplastic Syndrome With 65 Years or Older Compared to Youngers. A Retrospective Analysis of the Latin America Registry.
Journal: European journal of haematology
Published: April 26, 2025
A 31-year-old male with a plasmacytoid dendritic blast cell neoplasm.
Journal: Ecancermedicalscience
Published: June 14, 2024
Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes.
Journal: The Lancet. Haematology
Published: May 20, 2024
Alternative Dosing Schedules of Azacitidine: A Real-World Study Across South American Centers.
Journal: Clinical lymphoma, myeloma & leukemia
Published: December 30, 2023
Thrombocytopenic thrombotic purpura related to COVID-19 vaccine: apropos of 4 cases.
Journal: Hematology, transfusion and cell therapy
Published: August 07, 2023
Acquired paraneoplastic hemophilia secondary to Vater's ampulla adenocarcinoma
Journal: Medicina
Published: August 28, 2021
Ruxolitinib in severe COVID-19: Results of a multicenter, prospective, single arm, open-label clinical study to investigate the efficacy and safety of ruxolitinib in patients with COVID-19 and severe acute respiratory syndrome
Journal: Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina)
Published: April 26, 2021
Severe thrombocytopenia as a predictor of survival and response to hypomethylating agents in myelodysplastic syndromes: A Latin-American cohort of 212 patients.
Journal: American journal of hematology
Published: July 02, 2020
Last Updated: 09/26/2026